Swiss Biotech Day 2025

Aurealis Therapeutics Drug Safety Officer, Matleena Piiroinen, attended  the World Drug Safety Congress Europe 2025, that took place 7–8 October in Amsterdam, The Netherlands. As Europe’s leading forum for drug safety and pharmacovigilance, the congress provides an important platform to exchange knowledge and address the most pressing challenges faced by safety professionals. At Aurealis Therapeutics, patient safety is central to

Aurealis Therapeutics attended LSX World Congress USA, 16-17 September 2025 in Boston. This was a leading forum that brought together innovators, investors, and senior life science dealmakers to shape the future of healthcare. Representing Aurealis Therapeutics were Juha Yrjänheikki (CEO) and Laurent Décory (COO). Our team also had a presentation on Wednesday, 17 September at 12:45, where our multi-target technology